Quinoxaline, cataloged under CAS number 91-19-0, is a pivotal heterocyclic compound that garners considerable attention in chemical research and industrial applications. Its distinct structure, derived from the fusion of a benzene ring and a pyrazine ring, provides a robust foundation for a wide range of chemical syntheses. This versatility makes quinoxaline a prized reagent for organic chemists.

As a crucial pharmaceutical intermediate, quinoxaline is integral to the development of new medicines. Its molecular framework serves as a starting point for the creation of drug candidates, contributing to advancements in healthcare. The capacity to modify the quinoxaline structure allows for the fine-tuning of pharmacological properties, thereby enhancing its potential in drug discovery and development.

The comprehensive chemical profile of quinoxaline, encompassing its molecular formula (C8H6N2), molecular weight (130.14700), melting point (29-32 °C), and boiling point (220-223 °C), is essential for its precise application in chemical processes. When considering the purchase of quinoxaline, understanding these specifications is key to selecting the right product. The price of quinoxaline reflects its importance and the technical expertise involved in its synthesis. Research into optimizing quinoxaline production methods continues to ensure its widespread availability for various chemical and pharmaceutical applications.